Department of Psychology, Faculty of Education Sciences, University of Cordoba, C/ San Alberto Magno, s/n, 14071, Cordoba, Spain.
Maimónides Biomedical Research Institute of Cordoba, Reina Sofía University Hospital, C/ San Alberto Magno, s/n, 14071, Cordoba, Spain.
BMC Psychiatry. 2022 Feb 9;22(1):99. doi: 10.1186/s12888-022-03726-4.
Emotional disorders are common, and they have become more prevalent since the COVID-19 pandemic. Due to a high attendance burden at the specialized level, most emotional disorders in Spain are treated in primary care, where they are usually misdiagnosed and treated using psychotropic drugs. This contributes to perpetuate their illness and increase health care costs. Following the IAPT programme and the transdiagnostic approach, the PsicAP project developed a brief group transdiagnostic cognitive-behavioural therapy (tCBT) as a cost-effective alternative. However, it is not suitable for everyone; in some cases, one-on-one sessions may be more effective. The objective of the present study is to compare, in cost-benefit terms, group and individual tCBT with the treatment usually administered in Spanish primary care (TAU).
A randomized, controlled, multicentre, and single-blinded trial will be performed. Adults with mild to moderate emotional disorders will be recruited and placed in one of three arms: group tCBT, individual tCBT, or TAU. Medical data and outcomes regarding emotional symptoms, disability, quality of life, and emotion regulation biases will be collected at baseline, immediately after treatment, and 6 and 12 months later. The data will be used to calculate incremental cost-effectiveness and cost-utility ratios.
This trial aims to contribute to clinical practice research. The involvement of psychologists in primary care and the implementation of a stepped-care model for mental disorders are recommended. Group therapy and a transdiagnostic approach may help optimize health system resources and unblock waiting lists so that people can spend less time experiencing mental health problems.
ClinicalTrials.gov: NCT04847310; Protocols.io: bx2npqde. (April 19, 2021).
情绪障碍很常见，自 COVID-19 大流行以来，它们变得更为普遍。由于专科治疗的高负担，西班牙的大多数情绪障碍都在初级保健中治疗，而这些障碍通常在初级保健中被误诊，并使用精神药物治疗。这导致疾病持续存在，并增加医疗保健成本。在 IAPT 计划和跨诊断方法的基础上，PsicAP 项目开发了一种简短的团体跨诊断认知行为疗法（tCBT），作为一种具有成本效益的替代方法。然而，它并不适合所有人；在某些情况下，一对一的治疗可能会更有效。本研究的目的是从成本效益的角度比较团体和个体 tCBT 与西班牙初级保健中常用的治疗方法（TAU）。
将进行一项随机、对照、多中心、单盲试验。将招募轻度至中度情绪障碍的成年人，并将其分为三组：团体 tCBT、个体 tCBT 或 TAU。在基线、治疗后立即以及 6 个月和 12 个月后，将收集有关情绪症状、残疾、生活质量和情绪调节偏差的医疗数据和结果。将使用这些数据计算增量成本效益和成本效用比。
这项试验旨在为临床实践研究做出贡献。建议心理学家参与初级保健，并实施精神障碍的分级护理模式。团体治疗和跨诊断方法可能有助于优化卫生系统资源并疏通等待名单，以便人们可以减少花在心理健康问题上的时间。
ClinicalTrials.gov：NCT04847310；Protocols.io：bx2npqde。（2021 年 4 月 19 日）。
